Company intelligence / Profile preview

Finnish Vaccine Research

Ownership: Private
Development stage: Commercial

Overview

FVR has conducted over 160 vaccine studies across all age groups with thousands of participants annually. In 2023 alone it ran 26 trials against 11 different pathogens. Its work includes both pre-market clinical trials and large-scale post-marketing RWE studies leveraging Finland’s comprehensive health registers.

Therapeutic areas: Infectious Diseases
Modalities: Vaccine
Industry: Contract Research Organization

Partnerships

Pfizer Inc.Moderna Inc.Sanofi S.A.GlaxoSmithKline SA/GSK plc.MSD/Merck & Co.SeqirusJanssenBionetVactechNational authoritiesAcademic institutions

Beyond the preview

Go deeper on Finnish Vaccine Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Finnish Vaccine Research.

Explore the full profile